×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Coronavirus | Financial Markets | Infrastructure | Money | Vaccines | AstraZeneca to Create Separate Division for Vaccines | Antibody Therapies

AstraZeneca to Create Separate Division for Vaccines, Antibody Therapies

AstraZeneca
(AP)

Tuesday, 09 November 2021 10:42 AM

AstraZeneca is creating a separate division for vaccines and antibody therapies to be led by senior executive Iskra Reić, the drugmaker said on Tuesday, as it builds focus on its COVID-19 shot and development of coronavirus treatments.

Reuters reported in July the Anglo-Swedish company was exploring options for its vaccine business and expected to have greater clarity on the matter by the end of 2021.

The new unit will combine research and development, manufacturing, commercial and medical teams, a spokesperson said.

Digging In on COVID-19

"The team will be dedicated to our COVID-19 vaccine, our long-acting antibody combination and our developmental vaccine addressing multiple variants of concern, as well as to our existing portfolio for respiratory viral disease," he said.

The news was first reported by the Financial Times.

© 2022 Thomson/Reuters. All rights reserved.


StreetTalk
AstraZeneca is creating a separate division for vaccines and antibody therapies to be led by senior executive Iskra Reić, the drugmaker said on Tuesday, as it builds focus on its COVID-19 shot and development of coronavirus treatments.
AstraZeneca to Create Separate Division for Vaccines, Antibody Therapies
129
2021-42-09
Tuesday, 09 November 2021 10:42 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved